- Home
- ZCMD vs CTXR Comparison
ZCMD vs CTXR Comparison
Compare ZCMD & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- CTXR
- Stock Information
- Founded
- ZCMD 2012
- CTXR 2007
- Country
- ZCMD China
- CTXR United States
- Employees
- ZCMD N/A
- CTXR N/A
- Industry
- ZCMD Other Consumer Services
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- CTXR Health Care
- Exchange
- ZCMD Nasdaq
- CTXR Nasdaq
- Market Cap
- ZCMD 22.8M
- CTXR 18.7M
- IPO Year
- ZCMD 2020
- CTXR N/A
- Fundamental
- Price
- ZCMD $0.95
- CTXR $1.35
- Analyst Decision
- ZCMD
- CTXR Strong Buy
- Analyst Count
- ZCMD 0
- CTXR 3
- Target Price
- ZCMD N/A
- CTXR $53.00
- AVG Volume (30 Days)
- ZCMD 7.2K
- CTXR 360.0K
- Earning Date
- ZCMD 01-01-0001
- CTXR 08-12-2025
- Dividend Yield
- ZCMD N/A
- CTXR N/A
- EPS Growth
- ZCMD N/A
- CTXR N/A
- EPS
- ZCMD N/A
- CTXR N/A
- Revenue
- ZCMD $15,864,773.00
- CTXR N/A
- Revenue This Year
- ZCMD N/A
- CTXR N/A
- Revenue Next Year
- ZCMD N/A
- CTXR $851.67
- P/E Ratio
- ZCMD N/A
- CTXR N/A
- Revenue Growth
- ZCMD N/A
- CTXR N/A
- 52 Week Low
- ZCMD $0.86
- CTXR $0.65
- 52 Week High
- ZCMD $2.97
- CTXR $17.00
- Technical
- Relative Strength Index (RSI)
- ZCMD 44.28
- CTXR 49.89
- Support Level
- ZCMD $0.86
- CTXR $1.18
- Resistance Level
- ZCMD $0.96
- CTXR $1.45
- Average True Range (ATR)
- ZCMD 0.05
- CTXR 0.10
- MACD
- ZCMD 0.00
- CTXR -0.00
- Stochastic Oscillator
- ZCMD 50.00
- CTXR 62.96
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.